Lonza Group has been a dominant player in the contract development and manufacturing space for decades. We think the outlook for Lonza looks bright, especially as drug manufacturing becomes more ...

The FDA accepted applications for a golimumab biosimilar, while Samsung Biologics reported record sales, and a Japanese ...

When Joe Biden was President, trans people in the US could update the gender marker on file with the Social Security Administration, the gender marker on their passport with the State Department, and, ...

The trial is anticipated to enrol 462 subjects and aims to confirm the safety and efficacy of the combination.

Research on tropical health is a critical field that addresses both infectious and non-infectious diseases prevalent in ...

The murder of a US Border Patrol agent near the Canadian border appears to be linked to a radical leftist trans militant cult ...

FDA approved Ryoncil ® as the first and only therapy for pediatric patients 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), ...

What we thought would happen, what Project 2025 said would happen, and what Trump promised would happen is happening. After ...

Diag-Nose.io launches Houston office to advance precise respiratory care using AI and proteomics after a successful $2M seed ...

ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET Orion and Invenra announce discovery service and commercial ...

Some Kentucky hemp are questioning the legitimacy of how some medical cannabis cultivators got picked and the state auditor could be investigating the process.

First Drug Approved in New Class of Non-Opioid Pain Medicines; Agency Continues to Take Steps to Support New Approaches for Pain Management <p ...